Lisata Therapeutics (LSTA) earnings date: Nov 5, 2026
Lisata Therapeutics (LSTA) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026, after the close.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on LSTA
| Last price | $1.05 (+2.9%) |
|---|---|
| Normal 1-day range (±1σ) | ±5.0% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Lisata Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Lisata Therapeutics reports on Nov 5, 2026. One email the day before, with ATLAS’s read on Lisata Therapeutics. You can switch it off at any time.
Alert me before LSTA reportsFree to start. Creating an account takes under a minute.
Notify me when Lisata Therapeutics reports
Track LSTA free Add Lisata Therapeutics to a free ATLAS watchlist and see its next report date in one place.
LSTA earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| Last report | May 13, 2026 · Beat |
| Beat rate (last 4 reports) | 2 of 4 (50%) |
| Average EPS surprise | +20.0% |
| Average move around a report | ±9.6% (last 4) |
| Sector | Healthcare · Biotechnology |
Lisata Therapeutics earnings history: last 4 reports
Lisata Therapeutics last reported on May 13, 2026: EPS of $0.05 against an estimate of $0.03 (+66.7% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| May 13, 2026 | $0.03 | $0.05 | +66.7% | Beat | -5.5% |
| Nov 6, 2025 | $3.38 | $3.39 | +0.3% | In line | -12.0% |
| Aug 7, 2025 | -$0.65 | -$0.54 | +16.9% | Beat | -12.2% |
| May 8, 2025 | -$0.53 | -$0.55 | -3.8% | Miss | -8.7% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for LSTA
See the fair value, the probability range and the earnings history of Lisata Therapeutics on its ATLAS page.
Lisata Therapeutics (LSTA) stock analysisPlans from €3.99 a month.
Lisata Therapeutics earnings: frequently asked questions
When does Lisata Therapeutics (LSTA) report earnings?
Lisata Therapeutics is scheduled to report on Thursday, November 5, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does LSTA beat earnings estimates?
Of its last 4 reports with a recorded result, Lisata Therapeutics beat the EPS estimate 2 times; the average surprise was +20.0%. Past results do not predict the next one.
How much does LSTA move around earnings?
Over its last 4 reports the stock moved an average of 9.6% (absolute, from the close before the report day to the close after it), and finished higher 0 of 4 times.
Did Lisata Therapeutics beat earnings estimates last quarter?
Lisata Therapeutics last reported on May 13, 2026: EPS of $0.05 against an estimate of $0.03 (+66.7% surprise), a beat.
How much does LSTA usually move in a day?
On a normal trading day the ATLAS model puts LSTA’s one-day range at about ±5.0%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer